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SMethods: Between November 2005 and November 2011, 971 eligible patients (712
men; mean age ¼ 62.812.2 year-old) were analyzed in this study. AKI was deﬁned
using absolute change in serum creatinine (SCr; SCr within 24-hour after primary PCI
minus admission SCr), AKI was categorized as no AKI (SCr change, <0.3mg/dL),
mild AKI (SCr change, 0.3-<0.5 mg/dL), moderate AKI (SCr change, 0.5-<1.0 mg/
dL), and severe AKI (SCr change, 1.0mg/dL). The 12-month major adverse cardiac
events (MACEs) were deﬁned as death, recurrent MI, and revascularizations.
Results: Overall, 9.6% had AKI by SCr including 5.7% with mild AKI, 2.5% with
moderate AKI, and 1.4% with severe AKI. The patients with AKI were more likely to
be female, and had a higher Killip class, more often diabetics, lower left ventricular
ejection fraction, lower hemoglobin levels, and higher N-terminal pro-brain natriuretic
peptide levels (NT-proBNP). During the 12-month follow-up, 9.3% (n¼96) MACE
occurred. The 12-month MACEs for those with mild, moderate, and severe AKI were
25.0%, 40.9%, and 70.0% compared with 8.6% in those without AKI. Kaplan-Meier
survival curve showed that there was signiﬁcant difference in 12-month MACEs
according to the severity of AKI (log-rank p <0.001). The patients with AKI had
a signiﬁcantly higher 12-month MACEs compared with those without AKI (30.1%
versus 7.0%, p <0.001). In Cox proportional hazards model, presence of AKI (hazard
ratio [HR] 2.803, 95% conﬁdence interval [CI] 1.359–5.782; p¼0.005) in addition to
Killip class >2 (HR 1.913, 95%CI 1.023–3.580; p¼0.042), serum glucose levels (HR
1.005, 95%CI 1.002–1.007; p<0.001), and log-transformed NT-proBNP levels (HR
1.205, 95%CI 1.031–1.409; p¼0.019) was an independent predictor of 12-month
MACEs after adjusting for confounding variables.
Conclusions: The AKI immediately after primary PCI is common and associated with
poor prognosis, particularly in post-MI patients with heart failure. Further efforts are
required in these patients.
TCT-353
Long-term Clinical Outcomes in Patients with Renal Insufﬁciency After
Sirolimus-eluting Stent Implantation: Five-year Follow-up Results of the
J-Cypher Registry
Yasushi Fuku1, Kazushige Kadota1, Seiji Habara1, Hiroyuki Tanaka1,
Tsuyoshi Goto1, Kazuaki Mitsudo2, Takeshi Kimura3
1Kurashiki Central Hospital, Kurashiki, Japan, 2Kurashiki Central Hospital,
Okayama, Japan, 3Kyoto University, Kyoto, Japan
Background: We sought to evaluate the impact of baseline renal function on clinical
outcomes in sirolimus-eluting stent (SES) recipients in the real-world registry.
Methods: The design of the j-Cypher Registry was a multicenter prospective enroll-
ment of consecutive patients who underwent SES implantations from 41 centers in
Japan.We reviewed 5-year clinical outcomes of 10 775 patients who had undergone SES
implantation exclusively and successfully between August 2004 and December 2006.
The patients were stratiﬁed into 4 groups according to their estimated glomerular
ﬁltration rate (eGFR): Group I, eGFR 60 ml/min/1.73m2 (normal renal function);
Group II, eGFR<60 and30ml/min/1.73m2 (mild-moderate renal insufﬁciency [RI]);
Group III, eGFR<30 ml/min/1.73m2 and not on hemodialysis (HD) (severe RI without
HD); and Group IV, renal failure treated with HD (severe RI with HD).
Results: The rate of all-cause death increased with the deterioration in renal function.
For all-cause death, hazard ratio (HR) and 95% conﬁdence interval (95%CI) were as
follows: I vs. II, HR 2.16, 95%CI 1.89-2.47, p<0.001; I vs. III, HR 7.02, 95%CI 5.85-
8.42, p<0.001; I vs. IV, HR 10.71, 95%CI 9.15-12.53, p<0.001. The TLR rates of
non-severe RI groups were low and similar: I vs. II, HR 0.92, 95%CI 0.82-1.03,
p¼0.16; I vs. III, HR 1.27, 95%CI 0.99-1.63, p¼0.06; I vs. IV, HR 3.58, 95%CI 3.04-
4.22, p<0.001. The rates of stent thrombosis are shown in the ﬁgure.
Conclusions: The effect of RI on coronary intervention results with SES is hetero-
geneous in each clinical event.TCT-354
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Background: We report outcomes of PCIs done without onsite cardiac surgery and
compare them to contemporary outcomes using the National Cardiovascular DataB112 JACC Vol 62/18S1/Suppl B j OctobRegistry (NCDR) database. The NCDR Risk score is a useful tool to predict the risk of
in-patient mortality after PCI. We wanted to evaluate if this score is applicable to a VA
population and assess its use in predicting outcomes.
Methods: Major complications from the 400 cases(365 retrospective) were compared
to contemporary data from published NCDR database. NCDR risk scores were
calculated for all the patients and these were co-related with their outcomes. Kaplan
Meier (KM) Survival Analyses of low (<10), intermediate (10 to 30) and high (>30)
NCDR score patients was performed with 3 year mortality data.
Results: The patients were predominantly older males with multiple risk factors.
There were no in-patient deaths and only 1 patient required emergent CABG and
overall complication rates were similar to NCDR. Only 1 of the 83 (1.2%) patients
with a NCDR score <10 died while 21 of the 52 (40.4%) with a score >30 died within
3 years. KM survival analyses of patients were stratiﬁed by NCDR score conﬁrmed
signiﬁcant increase in the 3 year mortality of the patients with higher scores. This is
the ﬁrst report using the NCDR score in a VA population.Conclusions: PCI outcomes at the VA Louisville without onsite surgery are
comparable to NCDR. The NCDR score provides a convenient and efﬁcient way of
predicting long term outcomes after PCI in the VA and can assist improved resource
utilization within VA for PCI.
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Background: Reliable evaluation of absolute and relative risk of kidney injury after
coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI)
are unavailable. Therefore, we evaluated the risk of kidney injury after coronary artery
bypass grafting (CABG) as compared with that after percutaneous coronary inter-
vention (PCI) in patients with multivessel coronary artery disease.
Methods: Using a cohort from the ASAN-multivessel registry, we analyzed a total
of 5095 patients with multivessel coronary artery disease: 2473 patients had PCI
and 2622 patients had CABG. We used propensity-score matching to compare the
rates of the primary endpoint (death from any causes or chronic dialysis) at 5 year.
After propensity-score matching, there were 1717 matched pairs of patients, and
with no signiﬁcant differences were present between the two groups for any of the
covariates.
Results: During the hospitalization for index procedure, CABG group has higher
incidence of acute kidney injury stage 2 or 3 (0.7% vs. 4.7%, P<0.001). At long-
term, serum creatinine level (1.130.88mg/dL vs. 1.140.79mg/dL, P¼0.76) was
not different, but estimated glomerular ﬁltration rate was signiﬁcantly lower in
CABG group (68.223.3 vs. 73.323.2, P<0.001). Regarding clinical outcomes,
the risk of the primary end point at 5 years was signiﬁcantly lower in PCI group
than CABG group (hazard ratio [HR], 0.55; 95% conﬁdence interval [CI],
0.43–0.70, P<0.001). The risk of any dialysis was also lower in PCI group (HR
0.59; 95% CI 0.35-0.99, P¼0.044), mainly due to the lower risk of temporary
dialysis (HR 0.27; 95% CI 0.10-0.73, P¼0.01) but not due to the risk of chronic
dialysis (HR 0.27; 95% CI 0.10-0.73, P¼0.01) between two revascularization
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